Review
Lecanemab and Donanemab in Early-Stage Alzheimer’s Disease: Efficacy, Safety, and Challenges in Brazil
Ana Flávia, Almeida Lorenzoni, Gustavo A. B. Fonseca et al.
· 0 citations